An Observatory for the <i>MET</i> Oncogene: A Guide for Targeted Therapies
The <i>MET</i> proto-oncogene encodes a pivotal tyrosine kinase receptor, binding the hepatocyte growth factor (HGF, also known as scatter factor, SF) and governing essential biological processes such as organogenesis, tissue repair, and angiogenesis. The pleiotropic physiological functi...
Main Authors: | Dogus M. Altintas, Paolo M. Comoglio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/18/4672 |
Similar Items
-
MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor
by: Simona Gallo, et al.
Published: (2022-09-01) -
Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
by: Chiara Modica, et al.
Published: (2020-03-01) -
MET-Targeting Anticancer Drugs—De Novo Design and Identification by Drug Repurposing
by: Kenneth Kin-Wah To, et al.
Published: (2023-07-01) -
Aberrant <i>MET</i> Receptor Tyrosine Kinase Signaling in Glioblastoma: Targeted Therapy and Future Directions
by: Abdulhameed Al-Ghabkari, et al.
Published: (2024-01-01) -
Targeting <i>MET</i> Amplification: Opportunities and Obstacles in Therapeutic Approaches
by: Yuichi Kumaki, et al.
Published: (2023-09-01)